Gloria García – Meet the Advisory Board

, , ,
We are continuing to introduce the remarkable individuals who make up Gate2Brain’s external advisory…

Plug & Play Biotech Pitch

We have been invited by Plug & Play to pitch Gate2Brain at their Biotech focused pitch session on January…

The UB spin-off Gate2Brain wins the Senén Vilaró Prize for the development of technology that facilitates drug delivery to the brain

, ,
Barcelona, 20 December 2023 The University of Barcelona (UB) spin-off Gate2Brain has been awarded…

Gate2Brain among the 20 BioTech Startups to Watch in 2024

,
Innovations in biotech are transforming the healthcare, food, agriculture, and manufacturing industries.…

These 9 great medical ventures come from research institutions

,
When science and research leave the laboratories, the possibility arises of creating large medical and…

Gate2Brain, beyond barriers. An interview by Oncobites

, ,
A novel technological platform for the delivery of therapeutics across biological barriers   Meritxell…

Pablo Magnani – Meet the Advisory Board

, , , ,
We are continuing to introduce the remarkable individuals who make up Gate2Brain’s external advisory…

Bio-Europe 2023

,
Here, we are! Emerging from our enriching experience at Bio-Europe in Munich, where we were privileged…

Science Week 2023

This week, Gate2Brain ignited the spark of scientific wonder as our CEO, Meritxell Teixido , infused…

Inv€$tival Showcase – LSX

,
📅  Our Business Development Manager, Carles Taulé Flores, will be attending the 8th annual LSX…

Gate2Brain honored with an award as part of the EIT Health “Wild Card” program

, ,
Gate2Brain has recently been honored with an award as part of the EIT Health "Wild Card" program! What…

World Orphan Drug Congress Europe 2023

,
We're all geared up and excited for World Orphan Drug Congress Europe 2023❗❗ Gate2Brain is thrilled…

33rd Barcelona Investment Healthcare Forum

,
Gate2Brain, alongside 8 other health startups, is privileged to take part in the round presentations…

Finalist of EIT Health Wild Card Programme 2023

,
Gate2Brain has proudly earned a spot as a finalist in the esteemed 2023 EIT Health Wild Card Programme,…

G2B at Pediatric Diffuse Midline Glioma International Meeting

Gate2Brain was honored to participate in the Pediatric Diffuse Midline Glioma (DMG) International Meeting,…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social